Literature DB >> 18596726

ANCA patients have T cells responsive to complementary PR-3 antigen.

Jiajin Yang1, David J Bautz, Sofia Lionaki, Susan L Hogan, Hyunsook Chin, Roland M Tisch, John L Schmitz, Barrak M Pressler, J Charles Jennette, Ronald J Falk, Gloria A Preston.   

Abstract

Some patients with proteinase 3 specific anti-neutrophil cytoplasmic autoantibodies (PR3-ANCA) also have antibodies that react to complementary-PR3 (cPR3), a protein encoded by the antisense RNA of the PR3 gene. To study whether patients with anti-cPR3 antibodies have cPR3-responsive memory T cells we selected conditions that allowed cultivation of memory cells but not naïve cells. About half of the patients were found to have CD4+TH1 memory cells responsive to the cPR3(138-169)-peptide; while only a third of the patients had HI-PR3 protein responsive T cells. A significant number of T cells from patients responded to cPR3(138-169) peptide and to HI-PR3 protein by proliferation and/or secretion of IFN-gamma, compared to healthy controls while there was no response to scrambled peptide. Cells responsive to cPR3(138-169)-peptide were not detected in MPO-ANCA patients suggesting that this response is specific. The HLADRB1(*) 15 allele was significantly overrepresented in our patient group and is predicted to bind cPR3(138-169) peptide with high affinity. Regression analysis showed a significant likelihood that anti-cPR3 antibodies and cPR3-specific T cells coexist in individuals, consistent with an immunological history of encounter with a PR3-complementary protein. We suggest that the presence of cells reacting to potential complementary protein pairs might provide an alternative mechanism for auto-immune diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18596726      PMCID: PMC2754720          DOI: 10.1038/ki.2008.309

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  51 in total

1.  Separable effector T cell populations specialized for B cell help or tissue inflammation.

Authors:  D J Campbell; C H Kim; E C Butcher
Journal:  Nat Immunol       Date:  2001-09       Impact factor: 25.606

Review 2.  Specific interactions between sense and complementary peptides: the basis for the proteomic code.

Authors:  Jonathan R Heal; Gareth W Roberts; John G Raynes; Ashish Bhakoo; Andrew D Miller
Journal:  Chembiochem       Date:  2002-03-01       Impact factor: 3.164

3.  Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells.

Authors:  A E Lovett-Racke; J L Trotter; J Lauber; P J Perrin; C H June; M K Racke
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

4.  Ulcerative colitis in a renal transplant patient with previous Goodpasture disease.

Authors:  A M Hibbs; B Bznik-Cizman; M Guttenberg; B Goldberg; K Meyers
Journal:  Pediatr Nephrol       Date:  2001-07       Impact factor: 3.714

5.  Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides.

Authors:  Y M Van Der Geld; A Simpelaar; R Van Der Zee; J W Tervaert; C A Stegeman; P C Limburg; C G Kallenberg
Journal:  Kidney Int       Date:  2001-01       Impact factor: 10.612

6.  In vitro T lymphocyte responses to proteinase 3 (PR3) and linear peptides of PR3 in patients with Wegener's granulomatosis (WG).

Authors:  Y M van der Geld; M G Huitema; C F Franssen; R van der Zee; P C Limburg; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

7.  Resting small B cells present endogenous immunoglobulin variable-region determinants to idiotope-specific CD4(+) T cells in vivo.

Authors:  L A Munthe; J A Kyte; B Bogen
Journal:  Eur J Immunol       Date:  1999-12       Impact factor: 5.532

8.  In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3- and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase.

Authors:  E R Popa; C F M Franssen; P C Limburg; M G Huitema; C G M Kallenberg; J W Cohen Tervaert
Journal:  Arthritis Rheum       Date:  2002-07

9.  Leprosy in a high-prevalence Egyptian village: epidemiology and risk factors.

Authors:  Aly A Hegazy; Ibrahim A Abdel-Hamid; El-Shahat F Ahmed; Sabry M Hammad; Samia A Hawas
Journal:  Int J Dermatol       Date:  2002-10       Impact factor: 2.736

Review 10.  What you should know about PR3-ANCA. Structural aspects of antibodies to proteinase 3 (PR3).

Authors:  E Peen; R C Williams
Journal:  Arthritis Res       Date:  2000-06-12
View more
  22 in total

Review 1.  Epigenetics and complementary proteins.

Authors:  D Ciavatta; R J Falk
Journal:  Clin Exp Immunol       Date:  2011-05       Impact factor: 4.330

2.  Autoimmunity to the alpha 3 chain of type IV collagen in glomerulonephritis is triggered by 'autoantigen complementarity'.

Authors:  John Reynolds; Gloria A Preston; Barrak M Pressler; Peter Hewins; Michael Brown; Aleeza Roth; Elizabeth Alderman; Donna Bunch; J Charles Jennette; H Terence Cook; Ronald J Falk; Charles D Pusey
Journal:  J Autoimmun       Date:  2015-04-02       Impact factor: 7.094

Review 3.  Pathogenesis of ANCA-Associated Pulmonary Vasculitis.

Authors:  Marco A Alba; J Charles Jennette; Ronald J Falk
Journal:  Semin Respir Crit Care Med       Date:  2018-11-07       Impact factor: 3.119

4.  DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans.

Authors:  Yali Cao; John L Schmitz; Jiajin Yang; Susan L Hogan; Donna Bunch; Yichun Hu; Caroline E Jennette; Elisabeth A Berg; Frank C Arnett; J Charles Jennette; Ronald J Falk; Gloria A Preston
Journal:  J Am Soc Nephrol       Date:  2011-05-26       Impact factor: 10.121

Review 5.  Pathogenesis and treatment of ANCA-associated vasculitis-a role for complement.

Authors:  Damien Noone; Diane Hebert; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2016-09-05       Impact factor: 3.714

Review 6.  ANCA Glomerulonephritis and Vasculitis.

Authors:  J Charles Jennette; Patrick H Nachman
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-25       Impact factor: 8.237

7.  Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis.

Authors:  Sophia Lionaki; Elizabeth R Blyth; Susan L Hogan; Yichun Hu; Brent A Senior; Caroline E Jennette; Patrick H Nachman; J Charles Jennette; Ronald J Falk
Journal:  Arthritis Rheum       Date:  2012-10

Review 8.  B cell-mediated pathogenesis of ANCA-mediated vasculitis.

Authors:  J Charles Jennette; Ronald J Falk
Journal:  Semin Immunopathol       Date:  2014-04-29       Impact factor: 9.623

Review 9.  T cells in ANCA-associated vasculitis: what can we learn from lesional versus circulating T cells?

Authors:  Benjamin Wilde; Marielle Thewissen; Jan Damoiseaux; Pieter van Paassen; Oliver Witzke; Jan Willem Cohen Tervaert
Journal:  Arthritis Res Ther       Date:  2010-02-24       Impact factor: 5.156

Review 10.  Pathophysiology of ANCA-associated small vessel vasculitis.

Authors:  Cees G M Kallenberg
Journal:  Curr Rheumatol Rep       Date:  2010-12       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.